Watanabe Hikaru, Kamijima Yukari, Sato Tsugumichi, Kaufman David W, Kubota Kiyoshi
Department of Pharmacoepidemiology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.
Eur J Epidemiol. 2009;24(3):143-7. doi: 10.1007/s10654-009-9319-x. Epub 2009 Feb 11.
In our recent case-control study on the association between non-steroidal anti-inflammatory drugs (NSAIDs) and upper gastrointestinal bleeding (UGIB), the risk of UGIB was higher in non-drinkers than in heavy-drinkers. To explore this unexpected finding, we re-analyzed the data to test whether non-drinking represented risk factors for UGIB and also conducted an additional survey to find any disagreement with the original study that might suggest information bias. In the re-analysis, we estimated odds ratios (ORs) of UGIB by classifying 183 non-drinkers in the original study into 39 ex- and 144 never-drinkers. We also measured the prevalence of potential risk factors of UGIB in controls. In the new survey, we sent a self-administered questionnaire on previous alcohol consumption. In the re-analysis, the OR for ex-drinking (5.4) was higher and the OR for never-drinking (2.6) was lower than the OR for non- (ex- plus never-) drinking (3.2) in the original study. Ex-drinkers had higher prevalence of H. pylori infection, history of previous ulcer and use of GI drugs than other types of drinkers. The answers on their previous alcohol consumption were consistent between the original and new surveys both in cases (kappa = 0.74) and controls (kappa = 0.73). Ex-drinking may represent unmeasured risk factors for UGIB such as undiagnosed ulcer. In an observational study of UGIB, ex-drinking may be distinguished from never-drinking as a potential surrogate for UGIB risk. When prescribing an NSAID to an ex-drinker in clinical practice, one may make sure to explore whether an ex-drinker has a history of ulcer.
在我们最近一项关于非甾体抗炎药(NSAIDs)与上消化道出血(UGIB)关联的病例对照研究中,不饮酒者发生UGIB的风险高于重度饮酒者。为探究这一意外发现,我们重新分析了数据,以检验不饮酒是否代表UGIB的危险因素,还开展了一项补充调查,以查找可能提示信息偏倚的与原研究不一致之处。在重新分析中,我们将原研究中的183名不饮酒者分为39名既往饮酒者和144名从不饮酒者,估算UGIB的比值比(OR)。我们还测量了对照组中UGIB潜在危险因素的患病率。在新调查中,我们发放了一份关于既往饮酒情况的自填问卷。在重新分析中,既往饮酒者的OR(5.4)高于原研究中不(既往饮酒者加从不饮酒者)饮酒者的OR(3.2),从不饮酒者的OR(2.6)则较低。既往饮酒者幽门螺杆菌感染、既往溃疡病史和使用胃肠道药物的患病率高于其他类型饮酒者。病例组(kappa = 0.74)和对照组(kappa = 0.73)在原调查和新调查中关于既往饮酒情况的回答一致。既往饮酒可能代表了UGIB未测量的危险因素,如未诊断的溃疡。在一项关于UGIB的观察性研究中,既往饮酒可与从不饮酒区分开来,作为UGIB风险的潜在替代指标。在临床实践中给既往饮酒者开具NSAID时,应确保探究其是否有溃疡病史。